Literature DB >> 15370274

Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development.

Sybille Muller1.   

Abstract

Lymphocyte clonal restriction is caused by priming the immune system with an antigen and has been referred to infectious disease study as "original antigenic sin" (OAS), described first for influenza by Francis. OAS is a dominant feature of a normal immune response. Benefits of OAS come from the initial contact with the pathogen, which induces immunological memory. Memory is achieved by priming B and T cells of an immunologically naïve host, and confers protection against infection with the antigen-related pathogen. Thus, a restricted antibody response to viral or parasite antigens is not per se pathogenic. However, the interplay between a "locked-in" immune response and the high genetic variation of the pathogenic agent can result in a deception of the immune system. In the following, clonal restriction of the immune response to HIV is described by giving examples of restricted anti-HIV antibody formation in maternally infected children. Clonal restriction results in host resistance of infected individuals to emerging HIV variants and quasispecies. The problems of classical approaches of vaccine design in AIDS and the lack of protection in vaccinated patients is reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370274     DOI: 10.1080/08830180490432802

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  9 in total

1.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

2.  A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits.

Authors:  Edmond J Remarque; Bart W Faber; Clemens H M Kocken; Alan W Thomas
Journal:  Infect Immun       Date:  2008-03-31       Impact factor: 3.441

Review 3.  Norovirus vaccines: Correlates of protection, challenges and limitations.

Authors:  Nada M Melhem
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

4.  Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

Authors:  Christopher D O'Donnell; Amber Wright; Leatrice Vogel; Kobporn Boonnak; John J Treanor; Kanta Subbarao
Journal:  Clin Vaccine Immunol       Date:  2014-03-19

5.  Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.

Authors:  Barbara C Bachler; Michael Humbert; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2013-06-21       Impact factor: 4.602

Review 6.  Immunogenicity of infectious pathogens and vaccine antigens.

Authors:  Siddhartha Mahanty; Antoine Prigent; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-05-29       Impact factor: 3.615

Review 7.  Viral shape-shifting: norovirus evasion of the human immune system.

Authors:  Eric F Donaldson; Lisa C Lindesmith; Anna D Lobue; Ralph S Baric
Journal:  Nat Rev Microbiol       Date:  2010-02-02       Impact factor: 60.633

Review 8.  Multiantibody strategies for HIV.

Authors:  Andrew Hiatt; Larry Zeitlin; Kevin J Whaley
Journal:  Clin Dev Immunol       Date:  2013-06-06

Review 9.  Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.

Authors:  Katie L Flanagan; Emma Best; Nigel W Crawford; Michelle Giles; Archana Koirala; Kristine Macartney; Fiona Russell; Benjamin W Teh; Sophie Ch Wen
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.